With more than 16 years of experience in the UV water treatment (drinking water, waste water, industrial processes,…), BIO-UV, an innovative industrial SME, is the leading French manufacturer of ultraviolet light water treatment equipment, and leader in Europe.
Made up of 49 employees, the BIO-UV Group designs, manufactures and markets systems and concepts of disinfection by ultraviolet light (UV-C) for professionals, adapted to a large number of applications.
With a consolidated turnover of 12 million euros in 2015, BIO-UV markets its systems throughout the world. More than 75% of the group’s sales are made in export markets. Delta UV, the California-based manufacturer of UV-C technology and American subsidiary of the BIO-UV Group has been acquired by a water filtration and disinfection company.
Evoqua Water Technologies and its recently acquired Neptune-Benson business has purchased Delta Ultraviolet Corporation under the terms of the deal announced August 8 2016.
Delta UV was acquired by the French firm BIO-UV in 2006 and operated in North American markets.
The BIO-UV Group has decided to sell its American company specialised for commercial pools and spas in the residential American market.
The relationships of the 2 groups will be maintained through a conception and distribution cross-partnership established with the Neptune Benson/Evoqua Group.
The sale of the company will allow the BIO-UV Group to foster the technological development of its products in the residential pools and spas markets, and also comfort its leading position in the commercial pools sector.
Moreover, the Group intends to intensify its presence in the drinking water treatment, waste water, REUSE, and aquaculture… markets of extremely high potential of development worldwide.
Finally it will also allow BIO-SEA to make the future required technological and certification investments for the ballast water treatment market, in order to respond to every worldwide request.
The BIO-SEA filtration/disinfection system has already been type approved through many IMO and USCG tests campaigns (MPN and/or CMFDA), undertaken during the past 6 years with various laboratories (DHI, GO CONSULT, MERC…).
Futhermore BIO-UV will reinforce its areas of intervention and strengthen its Export team.
This sale is therefore an offensive strategic operation which allows the BIO-UV Group to remain independent and ensure its business development securely, increasing its turnover from 12 millions euros in 2015 to 40 millions in 2020.
For more information on the BIO-UV Group :